2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$16.05+$0.02 (+0.12%)
Price as of Jul 14, 2026 4:50 AM EDT- $2.1BMarket Cap
- 77.32%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$16.05+$0.02 (+0.12%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.03 | ||
Change | +$0.25 (+1.58%) | ||
Open | $15.71 | ||
High | $16.14 | ||
Low | $15.39 | ||
Previous Close | $15.78 | ||
Volume | 1,322,454 | ||
30-Day Average Volume | 2,190,286 | ||
1-Week Change | 3.49% | ||
1-Month Change | 1.33% | ||
1-Year Change | 77.32% | ||
3-Year Change | 45.86% | ||
5-Year Change | 34.59% | ||
Fundamentals | |||
Shares Outstanding | 128.6M | ||
Total Assets | $724.0M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $73.6M | ||
Net Income | $34.4M | ||
Free Cash Flow | $8.9M | ||
EBIT | $43.9M | ||
EBITDA | $48.7M | ||
Net Working Capital | $393.7M | ||
EPS | $0.25 | ||
Enterprise Value/EBITDA | 41 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 4 | ||
P/E | 64 | ||
PEG | -1 | ||
Price/Free Cash Flow | 233 | ||
Price/Operating Cash Flow | 63 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue